Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist.

Wu C, Chan MF, Stavros F, Raju B, Okun I, Mong S, Keller KM, Brock T, Kogan TP, Dixon RA.

Open source

DOI
10.1021/jm9700068
Published
1997-05-01
Container
J Med Chem
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/jm9700068,
  title = {Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist.},
  author = {Wu C and  Chan MF and  Stavros F and  Raju B and  Okun I and  Mong S and  Keller KM and  Brock T and  Kogan TP and  Dixon RA.},
  year = {1997},
  journal = {J Med Chem},
  doi = {10.1021/jm9700068},
  url = {https://doi.org/10.1021/jm9700068}
}

RIS

TY  - JOUR
TI  - Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist.
AU  - Wu C
AU  -  Chan MF
AU  -  Stavros F
AU  -  Raju B
AU  -  Okun I
AU  -  Mong S
AU  -  Keller KM
AU  -  Brock T
AU  -  Kogan TP
AU  -  Dixon RA.
PY  - 1997
JO  - J Med Chem
DO  - 10.1021/jm9700068
UR  - https://doi.org/10.1021/jm9700068
ER  - 

APA

C, W., MF, C., F, S., B, R., I, O., S, M., KM, K., T, B., TP, K., & RA., D. (1997). Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist.. J Med Chem. https://doi.org/10.1021/jm9700068

Source records